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Calcineurin inhibitors, such as cyclosporine A 
(CsA) and FK506, are potent immunosuppres-
sants used clinically for the treatment of a range 
of immune-mediated diseases, such as the re-
jection  of  solid  organ  allografts.  CsA  is  best 
characterized for its ability to inhibit effector   
T cell functions, predominantly by preventing 
the activation of the NFAT transcription fac-
tors (Hogan et al., 2003). Blocking the activa-
tion of NFATs prevents the transcription of 
many characteristic T cell effector cytokines, 
such as IL-2 (Northrop et al., 1994).
There are four calcium-responsive mem-
bers of the NFAT family, designated NFATc1 
through NFATc4 (Macian, 2005). All are re-
tained  in  an  inactive  state  in  the  cytosol  by 
phosphorylation of serines in an N-terminal 
Serine-rich region domain. Upon intracellular 
calcium influx, calmodulin displaces an auto-
inhibitory loop from the active site of the   
phosphatase  calcineurin  (Bram  and  Crabtree, 
1994). Calcineurin then removes the inhibitory 
phosphates, allowing NFATs to translocate to 
the nucleus where they collaborate with other 
transcription factors, such as AP-1, to effect 
changes  in  gene  transcription  (Clipstone  and 
Crabtree, 1992). Although NFATs have been 
extensively studied in the context of T cells, rel-
atively few studies have examined their function 
in myeloid lineages (Losa García et al., 1996; 
Dalmarco et al., 2008; Zanoni et al., 2009).
Despite  their  effectiveness  in  blocking   
T cell–mediated pathology, the use of calcineu-
rin inhibitors is tempered by their many adverse 
effects (Woo et al., 1997). One such toxicity 
with particularly high morbidity and mortality 
is infection with opportunistic fungal pathogens 
such as Candida albicans, Mucor sp., aspergillus, 
and  histoplasma.  Indeed,  invasive  candidal 
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Patients taking immunosuppressive drugs, like cyclosporine A (CsA), that inhibit calcineurin 
are highly susceptible to disseminated fungal infections, although it is unclear how these 
drugs suppress resistance to these opportunistic pathogens. We show that in a mouse model 
of disseminated Candida albicans infection, CsA-induced susceptibility to fungal infection 
maps to the innate immune system. To further define the cell types targeted by CsA, we 
generated mice with a conditional deletion of calcineurin B (CnB) in neutrophils. These 
mice displayed markedly decreased resistance to infection with C. albicans, and both  
CnB-deficient and CsA-treated neutrophils showed a defect in the ex vivo killing of  
C. albicans. In response to the fungal-derived pathogen-associated molecular pattern 
zymosan, neutrophils lacking CnB displayed impaired up-regulation of genes (IL-10, Cox2, 
Egr1, and Egr2) regulated by nuclear factor of activated T cells, the best characterized CnB 
substrate. This activity was Myd88 independent and was reproduced by stimulation with 
the (1,3) glucan curdlan, indicating that dectin-1, rather than toll-like receptors, is the 
upstream activator of calcineurin. Our results suggest that disseminated fungal infections 
seen in CsA-treated patients are not just a general consequence of systemic suppression of 
adaptive immunity but are, rather, a result of the specific blockade of evolutionarily  
conserved innate pathways for fungal resistance.
© 2010 Greenblatt et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
six months after the publication date (see http://www.rupress.org/terms). After   
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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responses  remains  incompletely  characterized  (Gross  et  al., 
2006; Hara et al., 2007; LeibundGut-Landmann et al., 2007).
In this paper, we further explore the effects of calcineurin 
inhibitors on immunity to fungal pathogens and show that   
increased susceptibility to fungal infections seen with CsA treat-
ment is not a generic effect of inhibiting adaptive immune re-
sponses. Rather, it is a consequence of specific inhibition of an 
innate immune pathway that regulates antifungal resistance in 
myeloid lineage leukocytes. We demonstrate that calcineurin 
activity is required for the candidacidal activity of neutrophils, 
as well as for transcriptional responses through the dectin-1   
receptor that regulate inflammatory responses to this pathogen.
RESULTS AND DISCUSSION
CsA acts on the innate immune system to block resistance 
to C. albicans infection
To determine whether CsA promotes fungal infection through 
effects on the innate or the adaptive immune system, Rag2/ 
mice, which lack an adaptive immune system, and WT mice 
were used in a model of disseminated fungal infection.   
Because C. albicans is the most common fungal pathogen in 
humans, we used a model of disseminated C. albicans infection 
in mice (Diekema et al., 2002; Schelenz, 2008). Mice of both 
infection has a mortality of up to 50% (De Rosa et al., 2009).   
By one estimate, CsA treatment leads to a fourfold increase 
in the risk for systemic fungal infection as compared with 
prednisolone- and azathioprine-based immunosuppressive reg-
imens in the first 6 mo after kidney transplant (Tharayil John 
et al., 2003). CsA has also been observed to promote suscepti-
bility to C. albicans infection in mouse models (Vecchiarelli 
et al., 1989). Despite the dire clinical outcome of disseminated 
fungal infections, the mechanism by which CsA influences 
host-fungal interactions remains largely unexplored.
Recent studies have identified a family of ITAM-containing 
C-type lectin receptors that is important for the detection 
and killing of fungi. Dectin-1, the best characterized member 
of this family, recognizes (1,3)-glucans in fungal cell walls, 
triggering phagocytosis, intracellular calcium flux, and cyto-
kine production (Ariizumi et al., 2000b; Brown et al., 2002, 
2003; LeibundGut-Landmann et al., 2007; Gross et al., 2009). 
Dectin-1–deficient mice are highly susceptible to infection 
with C. albicans (Taylor et al., 2007). Although Syk, CARD9, 
PLC-, and NFATs are all implicated in signaling down-
stream of dectin-1, the contribution of specific transcription 
factors to dectin-1–induced transcriptional responses and the 
physiological contribution of these pathways to antifungal   
Figure 1.  CsA suppresses innate resis-
tance to C. albicans infection. (A) Kaplan-
Meier survival curve showing the survival of 
C. albicans–infected mice. Rag2/ or WT 
control mice were infected with 105 C. albi-
cans yeasts by i.v. injection and then treated 
daily with 200 mg/kg CsA or vehicle control  
(n = 11–12 mice per group). Mice were then 
monitored daily for survival. P < 0.0001 by 
log-rank test comparing CsA-treated to  
vehicle-treated groups, with no significant 
difference between either Rag2/ or WT 
groups. Results are representative of three 
independent experiments. (B) Mice were  
infected as in A and histological analysis of 
the kidneys was performed 4 d after infection. 
C. albicans were visualized by PAS stain (pur-
ple, arrow). Histology is representative of four 
per group. Results are representative of three 
independent experiments. Bars: (left) 500 µm; 
(right) 100 µm. (C) CsA- or vehicle-treated 
Rag2/ or WT mice were infected with  
C. albicans as in A. Homogenates of the kid-
ney were made 4 d after infection and  
C. albicans quantitated by serial dilution and 
colony counting. Each dot represents the 
mean of two measurements taken from a 
single mouse. P < 0.0001 by comparing either  
CsA-treated group to the corresponding  
vehicle-treated group by an unpaired Stu-
dent’s t test. Results are representative of  
two independent experiments. Horizontal  
bars show the mean of the group. Error  
bars show SD.JEM VOL. 207, May 10, 2010  925
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genotypes  were  infected  with  105  C.  albicans  yeasts  by   
i.v. injection and then treated daily with 200 mg/kg CsA 
or vehicle. Both CsA-treated Rag2/ and CsA-treated 
WT mice showed a median survival of 4 d after challenge 
with the yeasts (Fig. 1 A). In contrast, the majority of both 
Rag2/ and WT mice treated with vehicle survived the   
14-d experiment. Treatment with CsA in the absence of in-
fection did not alter mouse survival (Fig. S1 A). Similar re-
sults were also obtained using a lower (40 mg/kg) dose of 
CsA (Fig. S1 B). To confirm that the CsA-treated mice died 
as a result of failure to control C. albicans infection, histologi-
cal analysis of the kidneys and quantitative assessments of re-
nal C. albicans burdens 4 d after infection were performed 
(Fig. 1, B and C). C. albicans was stained using the periodic 
acid-Schiff (PAS) stain. The kidneys of both Rag2/ and 
WT  mice  treated  with  CsA  showed  fulminant  infection 
with germinating hyphal C. albicans forms with no obvious 
difference in disease severity. In contrast, C. albicans levels 
were substantially lower in the kidneys of vehicle-treated 
mice. Collectively, these data indicate that CsA acts on the 
innate immune system to promote susceptibility to infection 
with C. albicans.
Mice with a conditional deletion of calcineurin B (CnB)  
in neutrophils fail to control C. albicans infection
To both further define the cell type responsible for suppres-
sion of antifungal immunity by CsA and to establish that the 
suppression is the result of a calcineurin-dependent effect of 
CsA, we generated mice with a conditional deletion of a CnB 
floxed allele by cre recombinase expressed under the lysozyme 
M promoter (hereafter, CnBLysM mice; Clausen et al., 1999; 
Neilson et al., 2004). To determine the efficiency of cre-
mediated recombination in different myeloid cell lineages, 
we measured CnB mRNA levels in neutrophils sorted from 
the  BM  and  spleen  as  a  CD11bhigh  Gr-1high  population   
(Fig. S1 C). Analysis of CnB expression by real-time PCR 
showed efficient deletion (90%) of CnB in neutrophils at 
both sites. Macrophages were also sorted from the spleen as 
CD11bint F4/80+ cells. In contrast to the efficient deletion 
seen in neutrophils, however, splenic macrophages showed no 
appreciable deletion of CnB. Peritoneal macrophages showed 
only modest deletion (50%). Hence, we attribute the effects 
described in the next paragraph primarily to the function of CnB 
in neutrophils, although we cannot rule out an additional con-
tribution from CnB in certain macrophage subsets.
Figure 2.  CnBLysM mice display increased susceptibility to fungal infection. (A) Kaplan-Meier survival curve showing the survival of C. albicans–
infected mice. CnBfl/fl or CnBLysM mice were infected with 105 C. albicans yeasts by i.v. injection (n = 10–11 mice per group). Mice were then monitored 
daily for survival. P < 0.0001 by the log-rank test. Results are representative of three independent experiments. (B) CnBLysM or control CnBfl/fl mice were 
infected with C. albicans as in A. Homogenates of the kidney were made 4 d after infection and C. albicans quantitated by serial dilution and colony 
counting. Each dot represents the mean of two measurements taken from a single mouse. P < 0.0001 by an unpaired Student’s t test. Results are repre-
sentative of three independent experiments. Horizontal bars show the mean of the group. Error bars show SD. (C) Histological analysis of the kidneys of  
C. albicans–infected mice 4 d after challenge. C. albicans were visualized by PAS stain (purple color). Histology is representative of four mice per group. 
Results are representative of three independent experiments. Bars, 100 µm.926 Calcineurin in neutrophil antifungal function | Greenblatt et al.
Figure 3.  Zymosan activates the calcineurin–NFAT pathway. (A) Primary neutrophils were isolated and treated with CsA or vehicle for 15 min  
before mixing 1:1 with C. albicans yeasts, strain SC 5314. At the indicated time points, aliquots were taken and CFUs of C. albicans determined by serial 
dilutions on YPD agar. Relative killing was determined by normalization to C. albicans added to medium without neutrophils. Results are representative of 
three independent experiments. (B) Expression of NFATc1, NFATc2, and NFATc3 was determined in neutrophils and macrophages as indicated by real-time 
PCR. Results are representative of three independent experiments. (C) Primary neutrophils stimulated with 100 µg/ml zymosan and blotted for expression 
of NFATc1. Results are representative of three independent assays. (D) Primary neutrophils were stimulated with zymosan for 30 min, and nuclear and 
cytoplasmic fractions were blotted for NFATc1. Results are representative of three independent experiments. (E) Primary neutrophils were stimulated with 
the indicated concentrations of zymosan for 12 h, and the supernatant levels of IL-10 and IL-6 were quantified by ELISA. Results are representative of 
three independent experiments. (F) Primary neutrophils were stimulated with zymosan for 6 h and the expression of Cox2 was determined by real-time 
PCR. Results are representative of three independent experiments. (G) NFATc1 NFATc3Mx neutrophils and neutrophils from double heterozygous 
NFATc1Mx/+ NFATc3Mx/+ mice were isolated and stimulated with 100 µg/ml zymosan. 12 h later, supernatants were harvested and IL-10 levels determined 
by ELISA. Results are representative of three independent experiments. Error bars show SD.JEM VOL. 207, May 10, 2010  927
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CnBlysM mice and littermate controls were infected with 
105 C. albicans, as in the previous section, and monitored for 
survival (Fig. 2 A). CnBlysM mice succumbed to C. albicans 
infection 7 d after challenge. As in the experiment pre-
sented in Fig. 1, the majority of control mice survived the 
14-d experiment. CFU counts measured from kidney tissue 
4 d after infection (Fig. 2 B) revealed a significantly higher 
renal burden of C. albicans in CnBlysM mice compared with 
controls, indicating death from a failure to control infection. 
Likewise, histological analysis of the kidneys revealed extensive 
PAS-positive lesions in CnBlysM mice containing germinating 
C. albicans hyphae and sheets of tissue-infiltrating neutrophils. 
In contrast, inflammatory infiltrates were much less frequent 
in control mice, and, when found, appeared to be nearly devoid 
of PAS-positive material, indicating effective fungal clearance 
(Fig. 2 C). Thus, similar to CsA-treated Rag2/ mice, CnBlysM 
mice display a dramatically increased susceptibility to systemic 
fungal infection.
Regulation of antifungal responses in neutrophils by calcineurin 
through NFAT-dependent and -independent pathways
When neutrophils encounter a pathogen, they attempt to 
limit infection by both directly killing the offending agent 
and producing molecules that promote an effective inflam-
matory response, including cytokines and prostanoids. To 
explain  the  observation  that  mice  deficient  in  calcineurin   
activity in innate immune cells succumb rapidly to C. albicans, 
the response of calcineurin-deficient neutrophils to this patho-
gen was further explored in vitro. First, we tested the role of 
calcineurin in fungicidal responses. Both CnB-deficient and 
CsA-treated neutrophils were defective in the ability to kill 
C. albicans within 30 min (Fig. 3 A). Similar results were ob-
tained with two C. albicans strains, SC5314 (Fig. 3 A) and 
NCCLS 11 (Fig. S1 E). CsA was not seen to directly affect   
C. albicans survival in the absence of neutrophils (Fig. S1 D). 
Likewise, C. albicans that were pretreated with CsA or vehi-
cle, washed thoroughly, and then added to neutrophils were 
found to induce equivalent IL-10 production, making it un-
likely that possible direct effects of CsA on yeast metabolism 
complicate the interpretation of these results (Fig. S1 D).   
Despite this difference in killing, classical effector pathways 
mediating the fungicidal activity of neutrophils, including   
degranulation, as monitored by myeloperoxidase release, and 
the production of nitric oxide, were unaltered by treatment 
with CsA (Fig. S2, A–C; Aratani et al., 1999). Likewise, CsA 
treatment or CnB deficiency did not affect reactive oxygen 
species (ROS) production or phagocytosis in response to   
zymosan or C. albicans (Fig. S4, E–G). Collectively, these data 
suggest that calcineurin regulates the ability of neutrophils to 
kill C. albicans through a novel anti-microbial pathway.
Next, we examined the transcriptional effector mecha-
nisms downstream of CnB in neutrophils leading to the con-
trol of inflammatory responses to fungal pathogens. Because 
NFAT transcription factors are the best characterized targets 
of calcineurin, we examined the expression of NFATc1, 
NFATc2, and NFATc3 in neutrophils and macrophages.   
Although  macrophages  expressed  NFATc1,  NFATc2,  and 
NFATc3, neutrophils only expressed NFATc1 and NFATc3 
(Fig. 3 B). We then examined if pathogen-associated mole-
cule patterns (PAMPs) from the fungal cell wall can activate 
the calcineurin–NFAT pathway. Neutrophils were purified 
from the BM of WT mice and stimulated with zymosan, an 
extract of yeast cell walls rich in (1,3)-glucans. A substantial 
increase in NFATc1 protein was seen after 6 h of stimulation 
(Fig. 3 C). To directly demonstrate that zymosan is able to   
activate NFATs, neutrophils were stimulated with zymosan and 
the activation status of NFATc1 was determined by monitor-
ing nuclear translocation (Fig. 3 D). Nuclear translocation of 
NFATc1 occurred after 30 min, demonstrating that zymosan 
activates NFATs in a manner consistent with previous reports 
in other myeloid cell types (Goodridge et al., 2007).
To elucidate the importance of the calcineurin–NFAT 
pathway on the antifungal transcriptional responses in neu-
trophils, WT, CnB-deficient, and CsA-treated neutrophils 
were stimulated with zymosan. Both CnB-deficient and 
CsA-treated neutrophils were defective in IL-10 production 
as measured by ELISA in supernatants 12 h after stimulation   
(Fig. 3 E). Previously, the induction of IL-10 after zymosan stim-
ulation has been noted to be dectin-1 dependent (Saijo et al., 
2007). Additional analysis by real-time PCR of neutrophils 6 h 
after zymosan stimulation showed that other known NFAT 
target genes, including Cox2, Egr1, and Egr2, were all induced 
by zymosan in WT cells and that this response was signifi-
cantly blunted in CnB-deficient and CsA-treated neutrophils 
(Fig. 3 F and Fig. S2 D; Goodridge et al., 2007; Lazarevic   
et al., 2009). In contrast, the production of IL-6 was not altered 
in CnB-deficient or CsA-treated neutrophils (Fig. S2 E).
Notably, although these in vitro studies focus on the func-
tions of CnB in neutrophils, CnB can function similarly in 
other myeloid lineages. Splenic macrophages isolated from 
CnBLysM mice displayed improved deletion (70%) of CnB 
after 5 d of ex vivo culture in the presence of 20 ng/ml   
M-CSF (Fig. S3 A). CsA-treated or CnB-deficient macrophages 
displayed a defect in IL-10 secretion in response to zymosan 
similar to that seen in neutrophils (Fig. S3 B). Similarly, treat-
ment with CsA blocked IL-10 and IL-12 secretion by primary 
splenic dendritic cells (Fig. S3C, D). Because neutrophils were 
not observed to produce detectable IL-12 in response to   
zymosan, the effects of CnB/CsA on antifungal responses are 
likely to be both broad, in that they affect many cell lineages, 
and specific with respect to their effects in any given lineage.
Because  NFATc1  and  NFATc3  are  the  major  NFAT 
family members expressed in neutrophils, we tested whether 
they were responsible for the production of IL-10 down-
stream of CnB. NFATc1 and NFATc3 floxed alleles were 
deleted using the inducible Mx-cre/poly I:C system. The 
resulting  NFATc1  NFATc3  doubly  deficient  neutrophils 
(NFATc1Mx NFATc3Mx) showed defective IL-10 production 
when stimulated with zymosan, which is similar to the defect 
seen in CnB-deficient neutrophils (Fig. 3 G). Mice with a 
deletion of only NFATc1 or NFATc3 alone showed little   
to no defect in IL-10 production (Fig. S4 A). Given that 928 Calcineurin in neutrophil antifungal function | Greenblatt et al.
These results make it unlikely that TLR-stimulatory con-
taminants confound the interpretation of curdlan as a selec-
tive activator of dectin-1 and not TLRs.
In summary, CsA acts on the innate immune system to 
suppress resistance in a model of disseminated fungal infec-
tions. This activity maps to the function of CnB in neu-
trophils, where it contributes to both immediate killing of   
C. albicans yeasts and transcriptional responses downstream   
of dectin-1.
Although calcineurin inhibitors are some of the most 
potent  immunosuppressants  available,  significant  toxicity 
limits their clinical use (Farkas et al., 2009). Understanding 
the biology of these adverse effects is critical for the rational 
design of immunosuppressants with greater clinical utility. 
In particular, patients taking calcineurin inhibitors are sus-
ceptible to infection with a range of opportunistic fungal 
pathogens, the most common of which is C. albicans (Diekema 
et al., 2002; Schelenz, 2008). In this paper, we demonstrate 
that CsA promotes fungal infection through suppression of 
innate immune antifungal responses, a function which is 
separable from its action to prevent T cell–mediated allograft 
rejection. Furthermore, these actions likely reflect inhibi-
tion of responses to fungal PAMPs through the dectin-1 re-
ceptor, although recent work has identified several related 
receptors, such as dectin-2, Mincle, and CLEC-2, that use 
similar signaling pathways and may likewise function up-
stream of CnB (Matsumoto et al., 1999; Ariizumi et al., 2000a; 
Wells et al., 2008; Kerrigan et al., 2009; Robinson et al., 2009; 
NFATc1  and  NFATc3  mediate  the  production  of  IL-10 
downstream of calcineurin, we examined if they might also 
be involved in promoting candidal killing. Interestingly, in 
contrast to neutrophils deficient in CnB (Fig. 3 A), NFATc1Mx 
NFATc3Mx neutrophils showed no defect in killing C. albi-
cans in vitro (Fig. S4 B). Moreover, NFATc1Mx NFATc3Mx 
mice showed no significant alteration in survival in a model 
of disseminated Candidemia (Fig. S4 C).
To examine if NFATs contribute to cytokine responses to 
zymosan in other myeloid cells, the expression of NFATc1-c3 
was considered in primary splenic dendritic cells. NFATc1-c3 
transcripts were present and the expression of NFATc1 and 
NFATc2 was induced in response to zymosan stimulation. 
On this basis, we generated dendritic cells deficient for 
NFATc1 and NFATc2 by breeding NFATc1 floxed allele 
NFATc2/ mice to the CD11c-cre deleter strain to generate 
NFATc1CD11c NFATc2/ mice. Splenic dendritic cells from 
these mice displayed defects in IL-12 and IL-10 production 
similar those seen with CsA treatment (Fig. S3 D). Dendritic 
cells lacking only NFATc1 or NFATc2 alone displayed little 
to no defect in IL-10 secretion (Fig. S3 F). Thus, the specific 
combination of NFATs responsible for cytokine production 
in response to zymosan varies from tissue to tissue.
Thus,  CnB  mediates  two  distinct  pathways  in  the   
response to C. albicans. One, which is likely to be NFAT in-
dependent, is responsible for the immediate killing of C. albi-
cans, and the other is mediated by NFATc1 and NFATc3 and 
is involved in transcriptional responses to this pathogen.
The dectin-1 receptor, and not toll-like receptors (TLRs),  
is upstream of CnB/CsA
Zymosan has been shown to activate both the dectin-1 re-
ceptor through (1,3)-glucans and TLRs, particularly TLR2 
(Dillon et al., 2006). Previous studies indicate that activation 
of dectin-1, but not TLRs, promotes the sustained elevations 
in intracellular calcium that are necessary to activate calcineu-
rin (Xu et al., 2009). To directly test whether the activation 
of dectin-1, and not TLRs, is upstream of the effects of 
CsA, WT or CnB-deficient neutrophils were stimulated with 
curdlan, which contains dectin-1–stimulatory (1,3)-glucans 
but lacks TLR-stimulatory motifs (Gringhuis et al., 2009). 
Similar to the results obtained with zymosan, both CsA-
treated and CnB-deficient neutrophils showed a defect in   
IL-10 production after stimulation with curdlan (Fig. 4 A). As 
expected, CsA did not alter the production of IL-10, TNF, 
or IL-6 in neutrophils stimulated with LPS, a pure TLR4   
agonist (Fig. S4 D). To confirm that contaminants with 
TLR-stimulating capacity in the curdlan preparation were 
not confounding the interpretation of this experiment, neu-
trophils were isolated from MyD88/ mice (Fig. 4 B). In the 
absence of MyD88, all TLR signaling, except for the activa-
tion of the TRIF pathway by TLR4 and TLR3, which are 
not targeted by fungal pathogens, is defective (Kawai et al., 
1999; Hoebe et al., 2003; Yamamoto et al., 2003). WT and 
MyD88/ neutrophils were equally sensitive to the ability of 
CsA to block IL-10 production downstream of curdlan (Fig. 4 B). 
Figure 4.  Dectin-1, and not TLRs, are upstream of CnB activation. 
(A) Primary neutrophils from the indicated genotypes were pretreated with 
CsA for 15 min and stimulated with 100 µg/ml curdlan. IL-10 secretion was 
determined after 12 h by ELISA. Results are representative of three inde-
pendent experiments. (B) Primary neutrophils from the indicated geno-
types were pretreated with CsA for 15 min and stimulated with 100 µg/ml 
curdlan. IL-10 secretion was determined after 12 h by ELISA. Results are 
representative of two independent experiments. Error bars show SD.JEM VOL. 207, May 10, 2010  929
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MATERIALS AND METHODS
Mice.  The  generation  of  NFATc1  floxed  allele  mice  was  previously   
described  (Aliprantis  et  al.,  2008;  Horsley  et  al.,  2008).  The  lysozyme   
M–cre strain was purchased from The Jackson Laboratory. The CD11c-cre 
strain was a gift from B. Reizis (Columbia University, New York, NY). 
CalcineurinB and Nfatc3 floxed allele mice were a gift from G. Crabtree 
(Stanford University, Palo Alto, CA; Neilson et al., 2004; Canté-Barrett   
et al., 2007). Rag2/ mice were maintained on the BALB/c background. 
CnBLysM mice were maintained on a mixed C57BL/6 × 129 background. 
For NFATc1 NFATc3Mx mice, Mx-cre was induced by three injections   
every 2 d of 500 µg poly I:C (Kühn et al., 1995). All mice were housed at 
the  Harvard  School  of  Public  Health,  and  experimental  protocols  were   
approved by the Harvard Institutional Animal Care and Use Committee.
Isolation and stimulation of neutrophils. Neutrophils were isolated by 
flushing femoral and tibial BM and lysing red blood cells in ACK buffer. 
The remaining cells were then layered over a three-part percoll density gra-
dient (55, 65, and 75% isotonic percoll/PBS) and centrifuged at 500 g for 
30 min at room temperature. The interface between the 65 and 75% layers 
was collected as the neutrophil-enriched fraction. This fraction was deter-
mined to be 95% Gr-1hi CD11bhi B220 CD4 CD8 neutrophils by 
FACS analysis. Microscopic analysis of nuclear morphology confirmed the 
FACS determination of purity. For stimulation and in vitro killing assays, 
neutrophils were cultured in RPMI 1640 supplemented with 10% heat- 
inactivated FCS, glutamine, penicillin, streptomycin, and 2-mercaptoethanol. 
Neutrophils were stimulated with 100 µg/ml zymosan (from Saccharomyces 
cerevisiae; Sigma-Aldrich) or 100 µg/ml curdlan (from Alcaligenes faecalis; 
Sigma-Aldrich) as indicated. Where CsA was used, cells were pretreated for 
15 min with CsA before stimulation. For in vitro studies, CsA was dissolved 
in ethanol and diluted 1,000× to obtain the indicated concentration. For in 
vivo studies CsA was prepared as an emulsion in 15% (volume/volume) 
ethanol/castor oil.
In vivo infection with C. albicans. C. albicans SC5314 was grown for 16 h 
in YPD broth and washed three times with PBS. Yeasts were then counted 
on a hemocytometer and suspended at a concentration of 106/ml, and 100 µl 
was injected into 8-wk-old mice of the indicated genotypes via i.v. tail vein 
injection. C. albicans was observed microscopically before injection and found 
to be >99% yeast/hyphal forms. Mice were monitored daily for 14 d. For de-
termination of candidal burdens, mice were euthanized 4 d after injection by 
CO2 narcosis, and kidneys were harvested and homogenized by mechanical 
disruption in PBS. Serial dilutions of this homogenate were plated on YPD 
agar and colonies enumerated to determine quantitative fungal CFU counts. 
For histological analysis of the kidney, animals were euthanized, and kidneys 
were harvested and fixed in 4% paraformaldehyde. They were then dehy-
drated through an ethanol/xylene series and embedded in paraffin. Sections 
were cut and stained with the PAS stain or hematoxylin and eosin.
Quantitative determination of expression by real-time PCR and 
ELISA. For mRNA expression studies, RNA was isolated using trizol (Invi-
trogen). cDNA was synthesized using the iScript kit (Bio-Rad Laboratories), 
and real-time PCR was performed using SYBR green mix (Applied Biosys-
tems). Primers for NFATc1, NFATc2, NFATc3, EGR1, and EGR2 were 
used as previously described (Lazarevic et al., 2009).
Nuclear/cytoplasmic fractionation and Western blotting. Nuclear/
cytoplasmic fractionation was performed using the NE-PER kit (Thermo 
Fisher Scientific) according to the manufacturer’s instructions. The subse-
quent fractions were run on SDS-PAGE and blotted using anti-NFATc1 
(clone 7A6; BD), Sp1 (PEP2; Santa Cruz Biotechnology, Inc.), and -actin 
(13E5; Cell Signaling Technology).
In vitro C. albicans killing assay. C. albicans strain NCCLS 11 was obtained 
from American Type Culture Collection. Primary neutrophils were mixed 1:1 
with C. albicans yeasts with gentle agitation at 37°C. At the indicated times, 10-µl 
Yamasaki et al., 2009). Thus, the disseminated fungal infec-
tions observed in CsA-treated patients are not a consequence 
of broad inhibition of T cell responses but rather reflect spe-
cific blockade of evolutionarily conserved innate pathways 
for sensing fungal pathogens. Our results also help explain the 
clinical observation that disseminated fungal infections occur 
more frequently in patients with neutropenia than those with 
congenital defects in lymphocyte development (De Rosa et al., 
2009). Moreover, this study highlights a broader role for cal-
cineurin and NFATs in immune responses beyond antigen 
receptor signaling because this pathway regulates responses in 
the myeloid compartment.
Despite the defect in the ex vivo killing of C. albicans by 
CsA-treated or CnB-deficient neutrophils, these mutant 
neutrophils did not display significant defects in any of several 
effector processes, such as phagocytosis, ROS production, 
myeloperoxidase degranulation, or NO production, suggesting 
that CnB instigates an as yet uncharacterized candidacidal 
effector mechanism. The disassociation between transcriptional 
responses to yeast/zymosan and immediate C. albicans killing 
seen in NFATc1 NFATc3-deficient neutrophils suggests 
that CnB mediates two pathways involved in the response to 
fungal pathogens.
In investigating the transcriptional pathways downstream 
of CnB, the production of IL-10 in particular was dependent 
on CnB and NFATc1/c3. Interestingly, although IL-10 is 
most often cited as an antiinflammatory cytokine and, in-
deed, directly suppresses the phagocytic and candidacidal   
activities of neutrophils in vitro, the role of IL-10 in C. albi-
cans resistance in vivo is less clear. Recent studies have corre-
lated high IL-10 production with reduced renal C. albicans 
burden and tissue damage in i.v. models of C. albicans infec-
tion (Roilides et al., 2000; Tavares et al., 2000; MacCallum 
et al., 2009). Further work is needed to define the balance 
between pro- and antiinflammatory cytokines that provides 
for efficient protection from invasive fungal infection. More-
over, it is possible that both the nature and relative impor-
tance of the transcriptional response may vary depending on 
the route and kinetics of fungal exposure.
In summary, the results presented in this paper implicate 
the calcineurin signaling axis as critical for fungal responses in 
myeloid cells and specifically implicate the innate immune 
system as the target of CsA most relevant to the pathogenesis 
of disseminated fungal infections. In vitro, CnB contributes 
both to the immediate killing of C. albicans yeasts and to cyto-
kine responses, particularly IL-10 production, to fungal PAMPs 
such as zymosan and curdlan. We propose that the combined 
defect in candidacidal activity and IL-10 production by calci-
neurin inhibition leads to both increased pathogen burden 
and a robust unchecked inflammatory response that pro-
motes excessive tissue damage and lethality. These results 
refocus inquiry into the mechanism of disseminated fungal 
infections in CsA-treated patients away from the effects of 
CsA to suppress adaptive immune responses and toward a 
specific  examination  of  dectin-1–dependent  responses  in 
myeloid cells.930 Calcineurin in neutrophil antifungal function | Greenblatt et al.
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aliquots were taken, neutrophils lysed by resuspending in 1 ml of water, and   
C. albicans CFU determined by serial dilution and colony counting on YPD agar.
ROS production. Primary neutrophils were cultured at a density of 2 × 
105 cells/well in a 96-well plate. At the indicated times after stimulation with 
100 µg/ml zymosan or a 1:1 addition of live Candia yeasts, aliquots were 
taken and mixed 1:1 with a solution of 2 mM luminol, and chemilumines-
cence was measured on a luminometer (2010; Monolight).
Splenic dendritic cell isolation. Dendritic cells were purified from the 
single cell suspensions of splenocytes using positive selection with anti-CD11c 
magnetic beads (Miltenyi Biotec), according to the manufacturer’s instruc-
tions. The resulting cells were confirmed to be >85% CD11chi dendritic cells 
by FACS analysis.
For macrophage cultures, total splenocytes were cultured in 24-well   
tissue culture plates in the presence of 20 ng/ml M-CSF for 5 d. Nonadher-
ent cells were removed by daily washing. The resulting cells were confirmed 
to by >95% CD11b+ macrophages by FACS.
Statistics. All statistical tests were calculated using Prism. For survival curves, 
error bars reflect standard error. All other values graphed are mean ± SD.
Online supplemental material. Fig. S1. provides controls for in vivo and 
in vitro studies using C. albicans. Fig. S2 shows that IL-6 production, ROS 
production, and neutrophil degranulation do not require CnB. Fig. S3 shows 
the contribution of CnB/NFATs to cytokine secretion in dendritic cells and 
macrophages. Fig. S4 shows no appreciable difference in susceptibility to 
fungal infections in NFATc1Mx NFATc3Mx mice, that CsA does not alter   
cytokine secretion after LPS stimulation, and unaltered phagocytosis after 
treatment of neutrophils with CsA. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20092531/DC1.
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